Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkholderia pseudomallei | 23 | 2020 | 34 | 3.910 |
Why?
|
| Coxiella burnetii | 10 | 2024 | 16 | 3.880 |
Why?
|
| Genome, Bacterial | 27 | 2020 | 114 | 3.510 |
Why?
|
| Phylogeny | 44 | 2022 | 612 | 3.130 |
Why?
|
| Leptospira | 6 | 2022 | 22 | 3.000 |
Why?
|
| Leptospirosis | 6 | 2022 | 26 | 2.970 |
Why?
|
| Melioidosis | 15 | 2020 | 21 | 2.770 |
Why?
|
| Staphylococcal Infections | 5 | 2023 | 64 | 2.640 |
Why?
|
| Bacillus anthracis | 20 | 2017 | 32 | 2.270 |
Why?
|
| Staphylococcus aureus | 6 | 2023 | 80 | 2.140 |
Why?
|
| Polymorphism, Single Nucleotide | 29 | 2019 | 638 | 2.000 |
Why?
|
| Genetic Variation | 12 | 2018 | 328 | 1.910 |
Why?
|
| Q Fever | 5 | 2016 | 7 | 1.910 |
Why?
|
| DNA, Bacterial | 27 | 2021 | 184 | 1.800 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2023 | 58 | 1.730 |
Why?
|
| Sequence Analysis, DNA | 23 | 2021 | 455 | 1.730 |
Why?
|
| Anthrax | 11 | 2015 | 17 | 1.380 |
Why?
|
| Zoonoses | 4 | 2017 | 19 | 1.370 |
Why?
|
| Carrier State | 4 | 2023 | 32 | 1.340 |
Why?
|
| Genomics | 6 | 2018 | 201 | 1.330 |
Why?
|
| Evolution, Molecular | 12 | 2018 | 249 | 1.290 |
Why?
|
| Genotype | 26 | 2016 | 641 | 1.060 |
Why?
|
| Milk | 4 | 2019 | 48 | 0.940 |
Why?
|
| Common Cold | 1 | 2023 | 5 | 0.930 |
Why?
|
| Cattle Diseases | 3 | 2016 | 21 | 0.840 |
Why?
|
| Rural Population | 3 | 2021 | 253 | 0.820 |
Why?
|
| Rivers | 1 | 2021 | 43 | 0.770 |
Why?
|
| Soil | 2 | 2022 | 129 | 0.760 |
Why?
|
| Genes, Bacterial | 8 | 2015 | 88 | 0.730 |
Why?
|
| Metagenome | 1 | 2019 | 28 | 0.720 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2019 | 5 | 0.690 |
Why?
|
| Educational Status | 1 | 2020 | 295 | 0.690 |
Why?
|
| Humans | 53 | 2023 | 34853 | 0.690 |
Why?
|
| Orientia tsutsugamushi | 1 | 2018 | 7 | 0.670 |
Why?
|
| Animals | 30 | 2024 | 14307 | 0.670 |
Why?
|
| Disease Outbreaks | 7 | 2015 | 155 | 0.630 |
Why?
|
| Adenoma | 1 | 2019 | 89 | 0.630 |
Why?
|
| Molecular Epidemiology | 13 | 2015 | 49 | 0.620 |
Why?
|
| Cholera | 3 | 2014 | 70 | 0.620 |
Why?
|
| Gene Transfer, Horizontal | 3 | 2018 | 24 | 0.610 |
Why?
|
| False Positive Reactions | 2 | 2016 | 25 | 0.610 |
Why?
|
| Poverty | 2 | 2017 | 316 | 0.610 |
Why?
|
| Cattle | 7 | 2017 | 472 | 0.590 |
Why?
|
| Minisatellite Repeats | 7 | 2010 | 17 | 0.550 |
Why?
|
| Ecuador | 3 | 2021 | 9 | 0.500 |
Why?
|
| Bacterial Typing Techniques | 11 | 2016 | 34 | 0.490 |
Why?
|
| Vibrio cholerae | 2 | 2011 | 98 | 0.490 |
Why?
|
| Soil Microbiology | 5 | 2021 | 48 | 0.480 |
Why?
|
| Classification | 1 | 2013 | 7 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 413 | 0.470 |
Why?
|
| Arizona | 4 | 2023 | 92 | 0.470 |
Why?
|
| Genetics, Population | 2 | 2011 | 66 | 0.460 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 18 | 0.440 |
Why?
|
| Prevalence | 4 | 2023 | 1425 | 0.420 |
Why?
|
| Polymerase Chain Reaction | 8 | 2012 | 430 | 0.410 |
Why?
|
| Burkholderia mallei | 4 | 2014 | 6 | 0.390 |
Why?
|
| Australia | 7 | 2018 | 76 | 0.380 |
Why?
|
| Goats | 3 | 2019 | 21 | 0.380 |
Why?
|
| Female | 13 | 2022 | 19873 | 0.310 |
Why?
|
| DNA, Ribosomal | 2 | 2021 | 35 | 0.300 |
Why?
|
| Geography | 7 | 2011 | 86 | 0.300 |
Why?
|
| Recombination, Genetic | 2 | 2018 | 90 | 0.290 |
Why?
|
| Tularemia | 3 | 2014 | 114 | 0.290 |
Why?
|
| Francisella tularensis | 3 | 2014 | 115 | 0.290 |
Why?
|
| Computational Biology | 3 | 2019 | 275 | 0.260 |
Why?
|
| Burkholderia | 2 | 2016 | 17 | 0.260 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2016 | 14 | 0.250 |
Why?
|
| Software | 2 | 2019 | 204 | 0.250 |
Why?
|
| Cluster Analysis | 10 | 2015 | 188 | 0.250 |
Why?
|
| Models, Genetic | 3 | 2018 | 149 | 0.250 |
Why?
|
| Glanders | 3 | 2014 | 4 | 0.250 |
Why?
|
| Male | 11 | 2023 | 18870 | 0.250 |
Why?
|
| Middle Aged | 7 | 2020 | 9642 | 0.250 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2561 | 0.250 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 555 | 0.240 |
Why?
|
| Nasal Cavity | 1 | 2023 | 11 | 0.230 |
Why?
|
| Base Sequence | 8 | 2012 | 932 | 0.230 |
Why?
|
| Bacteriological Techniques | 2 | 2012 | 13 | 0.220 |
Why?
|
| Mexico | 1 | 2023 | 223 | 0.220 |
Why?
|
| United States | 7 | 2017 | 3894 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2021 | 165 | 0.210 |
Why?
|
| Species Specificity | 6 | 2014 | 233 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 355 | 0.210 |
Why?
|
| Risk Factors | 2 | 2020 | 3414 | 0.200 |
Why?
|
| Ixodes | 1 | 2021 | 2 | 0.200 |
Why?
|
| Endemic Diseases | 1 | 2021 | 22 | 0.200 |
Why?
|
| Yersinia pestis | 2 | 2014 | 35 | 0.190 |
Why?
|
| Swine | 2 | 2022 | 182 | 0.190 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 1490 | 0.190 |
Why?
|
| Symbiosis | 1 | 2020 | 42 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 649 | 0.180 |
Why?
|
| Metagenomics | 1 | 2019 | 32 | 0.180 |
Why?
|
| Water Microbiology | 2 | 2017 | 72 | 0.180 |
Why?
|
| Disease Reservoirs | 2 | 2016 | 20 | 0.180 |
Why?
|
| Biological Warfare Agents | 2 | 2017 | 4 | 0.180 |
Why?
|
| Rats | 2 | 2017 | 3261 | 0.170 |
Why?
|
| Gene Duplication | 1 | 2018 | 23 | 0.170 |
Why?
|
| Mice | 3 | 2020 | 5668 | 0.170 |
Why?
|
| DNA Primers | 4 | 2012 | 269 | 0.160 |
Why?
|
| Feces | 1 | 2019 | 110 | 0.160 |
Why?
|
| Dogs | 2 | 2017 | 138 | 0.160 |
Why?
|
| Ascomycota | 1 | 2017 | 15 | 0.160 |
Why?
|
| Mycoses | 1 | 2017 | 29 | 0.160 |
Why?
|
| Chiroptera | 1 | 2017 | 20 | 0.160 |
Why?
|
| Mutation | 5 | 2024 | 1023 | 0.160 |
Why?
|
| Horses | 2 | 2014 | 24 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2016 | 257 | 0.150 |
Why?
|
| Deer | 1 | 2017 | 11 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2016 | 78 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 841 | 0.150 |
Why?
|
| Dairying | 1 | 2016 | 3 | 0.150 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2017 | 11 | 0.150 |
Why?
|
| Klebsiella Infections | 1 | 2016 | 6 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 1003 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2020 | 469 | 0.150 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 16 | 0.150 |
Why?
|
| Transportation | 1 | 2016 | 26 | 0.150 |
Why?
|
| Ticks | 1 | 2016 | 6 | 0.140 |
Why?
|
| Coxiella | 1 | 2016 | 3 | 0.140 |
Why?
|
| Cross Infection | 1 | 2016 | 38 | 0.140 |
Why?
|
| Plague | 2 | 2014 | 24 | 0.140 |
Why?
|
| Databases, Genetic | 3 | 2016 | 90 | 0.140 |
Why?
|
| Adaptation, Biological | 2 | 2013 | 23 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2019 | 288 | 0.140 |
Why?
|
| Bayes Theorem | 2 | 2015 | 91 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2016 | 429 | 0.130 |
Why?
|
| Papua New Guinea | 2 | 2011 | 20 | 0.130 |
Why?
|
| Vibrio cholerae O1 | 1 | 2014 | 11 | 0.130 |
Why?
|
| Base Pair Mismatch | 2 | 2012 | 13 | 0.130 |
Why?
|
| Sheep Diseases | 1 | 2014 | 4 | 0.130 |
Why?
|
| Electrophoresis, Capillary | 2 | 2012 | 20 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2020 | 583 | 0.120 |
Why?
|
| Brucellaceae | 1 | 2013 | 1 | 0.120 |
Why?
|
| Georgia | 1 | 2014 | 155 | 0.120 |
Why?
|
| beta-Lactamases | 1 | 2013 | 33 | 0.120 |
Why?
|
| Burkholderia Infections | 1 | 2013 | 2 | 0.120 |
Why?
|
| Europe | 4 | 2017 | 88 | 0.120 |
Why?
|
| Escherichia coli Infections | 1 | 2013 | 39 | 0.120 |
Why?
|
| Bioterrorism | 3 | 2008 | 18 | 0.110 |
Why?
|
| Sequence Homology | 2 | 2009 | 34 | 0.110 |
Why?
|
| Brucella melitensis | 1 | 2012 | 1 | 0.110 |
Why?
|
| Brucella suis | 1 | 2012 | 1 | 0.110 |
Why?
|
| Heroin | 1 | 2012 | 11 | 0.110 |
Why?
|
| Mass Screening | 1 | 2016 | 427 | 0.110 |
Why?
|
| Brucella abortus | 1 | 2012 | 5 | 0.110 |
Why?
|
| Virulence | 4 | 2015 | 221 | 0.110 |
Why?
|
| Ceftazidime | 1 | 2012 | 1 | 0.110 |
Why?
|
| Methicillin Resistance | 1 | 2012 | 12 | 0.110 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2011 | 3 | 0.110 |
Why?
|
| Asia, Southeastern | 1 | 2011 | 11 | 0.110 |
Why?
|
| Cryptococcus gattii | 1 | 2011 | 7 | 0.110 |
Why?
|
| Animal Structures | 1 | 2011 | 14 | 0.110 |
Why?
|
| Chromosome Inversion | 1 | 2011 | 4 | 0.110 |
Why?
|
| Recreation | 1 | 2011 | 29 | 0.100 |
Why?
|
| Incidental Findings | 1 | 2011 | 10 | 0.100 |
Why?
|
| Gene Frequency | 1 | 2011 | 155 | 0.100 |
Why?
|
| Cryptococcosis | 1 | 2011 | 35 | 0.100 |
Why?
|
| Pneumonia | 1 | 2011 | 50 | 0.100 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2012 | 123 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 165 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2013 | 436 | 0.100 |
Why?
|
| Asia | 3 | 2017 | 74 | 0.090 |
Why?
|
| Adult | 4 | 2020 | 11034 | 0.090 |
Why?
|
| Brucella | 1 | 2009 | 4 | 0.090 |
Why?
|
| Forensic Sciences | 2 | 2008 | 2 | 0.090 |
Why?
|
| Virulence Factors | 3 | 2016 | 113 | 0.090 |
Why?
|
| Algorithms | 1 | 2011 | 435 | 0.090 |
Why?
|
| Bacteria | 1 | 2012 | 245 | 0.080 |
Why?
|
| North America | 3 | 2017 | 60 | 0.080 |
Why?
|
| Bacterial Proteins | 5 | 2013 | 520 | 0.080 |
Why?
|
| Tandem Repeat Sequences | 1 | 2007 | 9 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 6448 | 0.080 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 2013 | 27 | 0.080 |
Why?
|
| Ape Diseases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2012 | 203 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2024 | 141 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2003 | 15 | 0.060 |
Why?
|
| Reproduction | 1 | 2024 | 63 | 0.060 |
Why?
|
| Nepal | 2 | 2014 | 14 | 0.060 |
Why?
|
| Spleen | 1 | 2024 | 192 | 0.060 |
Why?
|
| Haiti | 2 | 2014 | 59 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 88 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 62 | 0.060 |
Why?
|
| Environmental Microbiology | 2 | 2016 | 26 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 200 | 0.050 |
Why?
|
| Biodiversity | 2 | 2013 | 81 | 0.050 |
Why?
|
| Genetic Markers | 2 | 2016 | 118 | 0.050 |
Why?
|
| Arthropod Vectors | 1 | 2021 | 2 | 0.050 |
Why?
|
| Northwestern United States | 1 | 2021 | 5 | 0.050 |
Why?
|
| Tick Infestations | 1 | 2021 | 4 | 0.050 |
Why?
|
| Climate | 1 | 2021 | 14 | 0.050 |
Why?
|
| Lyme Disease | 1 | 2021 | 16 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2012 | 61 | 0.050 |
Why?
|
| Climate Change | 1 | 2021 | 33 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 112 | 0.050 |
Why?
|
| Alleles | 2 | 2012 | 284 | 0.050 |
Why?
|
| Chromosomes, Bacterial | 2 | 2012 | 20 | 0.050 |
Why?
|
| Inhalation Exposure | 2 | 2011 | 37 | 0.050 |
Why?
|
| Water | 1 | 2022 | 283 | 0.050 |
Why?
|
| California | 1 | 2021 | 436 | 0.040 |
Why?
|
| Australasia | 1 | 2018 | 2 | 0.040 |
Why?
|
| New Guinea | 1 | 2018 | 5 | 0.040 |
Why?
|
| History, Ancient | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2013 | 80 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 348 | 0.040 |
Why?
|
| Nose | 1 | 2017 | 14 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2017 | 29 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 51 | 0.040 |
Why?
|
| Thailand | 2 | 2007 | 48 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2022 | 1352 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.040 |
Why?
|
| Housing, Animal | 1 | 2016 | 11 | 0.040 |
Why?
|
| Taq Polymerase | 2 | 2006 | 4 | 0.040 |
Why?
|
| Indiana | 1 | 2015 | 15 | 0.030 |
Why?
|
| Drug Users | 1 | 2015 | 42 | 0.030 |
Why?
|
| Bahrain | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hungary | 1 | 2014 | 9 | 0.030 |
Why?
|
| History, Medieval | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 70 | 0.030 |
Why?
|
| Tooth | 1 | 2014 | 12 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 165 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 21 | 0.030 |
Why?
|
| Africa | 1 | 2014 | 62 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2013 | 4 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 18 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 103 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 87 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 145 | 0.030 |
Why?
|
| Brucellosis | 1 | 2012 | 8 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2012 | 9 | 0.030 |
Why?
|
| Exhumation | 1 | 2012 | 1 | 0.030 |
Why?
|
| Utah | 1 | 2012 | 9 | 0.030 |
Why?
|
| Base Composition | 1 | 2012 | 22 | 0.030 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 9 | 0.030 |
Why?
|
| Methicillin | 1 | 2012 | 5 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2012 | 24 | 0.030 |
Why?
|
| Tetracycline | 1 | 2012 | 17 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 56 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 89 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2012 | 28 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 46 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2012 | 34 | 0.030 |
Why?
|
| Genome, Fungal | 1 | 2011 | 21 | 0.030 |
Why?
|
| Operon | 1 | 2011 | 43 | 0.030 |
Why?
|
| Georgia (Republic) | 1 | 2011 | 1 | 0.030 |
Why?
|
| Mammals | 1 | 2012 | 96 | 0.030 |
Why?
|
| Bacteriophages | 1 | 2012 | 43 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2012 | 89 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 142 | 0.030 |
Why?
|
| Genome | 1 | 2011 | 117 | 0.020 |
Why?
|
| Population Groups | 1 | 2011 | 56 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 650 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 211 | 0.020 |
Why?
|
| Pakistan | 1 | 2009 | 21 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 185 | 0.020 |
Why?
|
| Ochrobactrum anthropi | 1 | 2009 | 1 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2008 | 11 | 0.020 |
Why?
|
| China | 1 | 2009 | 178 | 0.020 |
Why?
|
| Russia | 1 | 2008 | 24 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 14 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 271 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 901 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 105 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 299 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 129 | 0.020 |
Why?
|
| Gorilla gorilla | 1 | 2006 | 4 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2006 | 7 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2006 | 21 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 74 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 600 | 0.020 |
Why?
|
| Nucleotides | 1 | 2005 | 33 | 0.020 |
Why?
|
| Hypertension | 1 | 2011 | 770 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 592 | 0.020 |
Why?
|
| Child | 1 | 2011 | 2875 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 965 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 71 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4012 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 287 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 5035 | 0.010 |
Why?
|